Ignite Creation Date:
2025-12-24 @ 2:09 PM
Ignite Modification Date:
2025-12-27 @ 10:43 PM
Study NCT ID:
NCT00351195
Status:
TERMINATED
Last Update Posted:
2008-08-26
First Post:
2006-07-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)
Sponsor:
Rigshospitalet, Denmark
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
etoxel-01-2005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |